Bain Capital Life Sciences Investors, LLC
21 holdingsFiling period: 2026-06-30Current AUM: $1.51Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | KLRA | Kailera Therapeutics Inc | 22.58M | $497.5M | $291.1M | 19.25% | -- | 2026-06-30 |
| 2 | HTFL | Heartflow Inc | 8.45M | $247.9M | $469.6M | 31.06% | -2,000,000 | 2026-06-30 |
| 3 | — | Newamsterdam Pharma Company | 3.81M | $129.0M | $129.0M | 8.53% | -3,500,000 | 2026-06-30 |
| 4 | SVRA | Savara Inc | 17.60M | $108.4M | $83.8M | 5.54% | -- | 2026-06-30 |
| 5 | — | Alkermes PLC | 1.94M | $101.5M | $101.5M | 6.72% | +1.33M | 2026-06-30 |
| 6 | SLDB | Solid Biosciences Inc | 9.81M | $98.0M | $62.8M | 4.15% | -- | 2026-06-30 |
| 7 | — | Pharvaris N V | 2.68M | $92.5M | $92.5M | 6.12% | -- | 2026-06-30 |
| 8 | OLMA | Olema Pharmaceuticals Inc | 7.09M | $88.6M | $51.4M | 3.40% | -387,989 | 2026-06-30 |
| 9 | COAG | Hemab Therapeutics Holdings Inc | 1.65M | $60.6M | $56.4M | 3.73% | -- | 2026-06-30 |
| 10 | CABA | Cabaletta Bio Inc | 17.24M | $53.6M | $27.8M | 1.84% | +7.56M | 2026-06-30 |
| 11 | XFOR | X4 Pharmaceuticals Inc | 7.97M | $37.2M | $24.1M | 1.59% | -- | 2026-06-30 |
| 12 | DNTH | Dianthus Therapeutics Inc | 362.5K | $35.3M | $28.5M | 1.89% | -- | 2026-06-30 |
| 13 | CCCC | C4 Therapeutics Inc | 7.17M | $33.5M | $22.7M | 1.50% | -- | 2026-06-30 |
| 14 | KYTX | Kyverna Therapeutics Inc | 2.88M | $25.7M | $17.4M | 1.15% | -225,000 | 2026-06-30 |
| 15 | ANNX | Annexon Inc | 4.44M | $25.3M | $17.0M | 1.12% | -774,943 | 2026-06-30 |
| 16 | RPID | Rapid Micro Biosystems Inc | 8.43M | $14.6M | $6.5M | 0.43% | -- | 2026-06-30 |
| 17 | IRON | Disc Medicine Inc | 141.2K | $10.3M | $11.2M | 0.74% | -- | 2026-06-30 |
| 18 | AVIR | Atea Pharmaceuticals Inc | 2.08M | $9.7M | $9.3M | 0.61% | -284,999 | 2026-06-30 |
| 19 | XLO | Xilio Therapeutics Inc | 664.0K | $6.4M | $5.7M | 0.38% | -- | 2026-06-30 |
| 20 | UPB | Upstream Bio Inc | 600.9K | $4.2M | $1.7M | 0.11% | -266,262 | 2026-06-30 |
| 21 | — | Newamsterdam Pharma Company | 100.0K | $2.1M | $2.1M | 0.14% | -- | 2026-06-30 |
← Scroll →